Search details
1.
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
Lancet Oncol
; 22(4): 489-498, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33794206
2.
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial.
JAMA Oncol
; 4(7): 977-984, 2018 07 01.
Article
in English
| MEDLINE | ID: mdl-29566104
3.
Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure.
Curr Med Res Opin
; 27(7): 1339-46, 2011 Jul.
Article
in English
| MEDLINE | ID: mdl-21627396
4.
Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.
Curr Med Res Opin
; 26(6): 1519-30, 2010 Jun.
Article
in English
| MEDLINE | ID: mdl-20429833
Results
1 -
4
de 4
1
Next >
>>